Shenouda Maged

EDGAR CIK 0001658369

Relmada Therapeutics, Inc. - RLMD

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Chief Financial Officer
Direct Buys
3
$149,701
53,432 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/11/2024
09/11/2024
Buy
24,120 @ $2.95
 $71,154 88,335 (37.56%) Direct
09/10/2024
09/11/2024
Buy
21,118 @ $2.73
 $57,652 64,215 (49.00%) Direct
09/09/2024
09/11/2024
Buy
8,194 @ $2.55
 $20,895 43,097 (23.48%) Direct